Patent details

Basic Information

Publication number:

EP1895005

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP070210471

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Cell-permeable peptide inhibitors of the JNK signal transduction pathway

French Title of Invention:

Inhibiteurs peptidiques à perméabilité cellulaire du processus de transduction du signal de JNK

German Title of Invention:

Zelldurchlässige Peptidhemmer des JNK-Signaltransduktionsweges

SPC Number:

Dates

Filing date:

12/10/2000

Grant date:

26/07/2017

EP Publication Date:

05/03/2008

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/07/2017

EP B1 Publication Date:

26/07/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/10/2017

Expiration date:

12/10/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/07/2017

 

 

Name:

Xigen Inflammation Ltd.

Address:

Arch. Makariou III 195 Neocleous House, 3030 Limassol, Cyprus (CY)

Inventor

Name:

Bonny, Christophe

Address:

Switzerland (CH)

Priority

1

Priority Number:

158774 P

Priority Date:

12/10/1999

Priority Country:

United States (US)

2

Priority Number:

503954

Priority Date:

14/02/2000

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; C07K 14/47;

Publication

European Patent Bulletin

Issue number:

201730

Publication date:

26/07/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
28/02/2018	Outgoing Correspondence	1